We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUR icon
11701
CALL
Aurora
AUR
$13.7B
$61K ﹤0.01%
32,000
-25,200
-44% -$92.7K
BCDA icon
11702
CALL
BioCardia
BCDA
$14.7M
$61K ﹤0.01%
2,740
+1,793
+189% +$42.9K
CKPT
11703
DELISTED
Checkpoint Therapeutics
CKPT
$61K ﹤0.01%
5,929
-12,053
-67% -$158K
CVRX icon
11704
PUT
CVRx
CVRX
$82.1M
$61K ﹤0.01%
+10,100
New +$58.1K
MRSN
11705
PUT
DELISTED
Mersana Therapeutics
MRSN
$61K ﹤0.01%
524
-124
-19% -$11.7K
RTB
11706
CALL
RTB Digital
RTB
$237M
$61K ﹤0.01%
165
+67
+68% +$64.5K
WRAP icon
11707
Wrap Technologies
WRAP
$105M
$61K ﹤0.01%
+32,883
New +$78K
ZDGE icon
11708
CALL
Zedge
ZDGE
$38.4M
$61K ﹤0.01%
21,200
-7,700
-27% -$38.1K
CGNT icon
11709
PUT
Cognyte Software
CGNT
$674M
$60K ﹤0.01%
14,200
-5,700
-29% -$40K
RNAC icon
11710
PUT
Cartesian Therapeutics
RNAC
$267M
$60K ﹤0.01%
1,520
+1,147
+308% +$34K
TROO icon
11711
CALL
TROOPS Inc
TROO
$243M
$60K ﹤0.01%
28,500
-1,900
-6% -$5.71K
ULBI icon
11712
PUT
Ultralife
ULBI
$125M
$60K ﹤0.01%
+13,200
New +$65K
WPRT
11713
PUT
Westport Fuel Systems
WPRT
$33.4M
$60K ﹤0.01%
5,920
-4,410
-43% -$54.6K
DO
11714
DELISTED
Diamond Offshore Drilling, Inc.
DO
$60K ﹤0.01%
+10,173
New +$76K
BGRY
11715
PUT
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$60K ﹤0.01%
41,400
-1,500
-3% -$3.31K
DS
11716
CALL
DELISTED
Drive Shack Inc.
DS
$60K ﹤0.01%
44,000
+21,900
+99% +$31.2K
HCARW
11717
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$60K ﹤0.01%
600,000
-150,100
-20% -$26.5K
RXRAW
11718
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
$60K ﹤0.01%
397,613
-2,667
-0.7% -$706
ASZ.WS
11719
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$60K ﹤0.01%
490,975
-9,025
-2% -$3.46K
SRAX
11720
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$60K ﹤0.01%
+17,938
New +$66.3K
LSTA icon
11721
CALL
Lisata Therapeutics
LSTA
$9.82M
$59K ﹤0.01%
7,373
-1,460
-17% -$12K
LYG icon
11722
CALL
Lloyds Banking Group
LYG
$90.1B
$59K ﹤0.01%
28,900
+4,200
+17% +$9.27K
MCRB icon
11723
PUT
Seres Therapeutics
MCRB
$45.6M
$59K ﹤0.01%
865
-80
-8% -$6.89K
OPFI icon
11724
PUT
OppFi
OPFI
$610M
$59K ﹤0.01%
17,800
-11,000
-38% -$35.4K
PTPI
11725
DELISTED
Petros Pharmaceuticals
PTPI
$59K ﹤0.01%
286
+10
+4% +$2.5K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.